# L-Arginine, Vascular Response and Mechanisms

> **NCT01482247** · PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 25 (actual)

## Conditions studied

- Hypertension
- Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** L-Arginine
- **DIETARY_SUPPLEMENT:** Placebo Supplement

## Key facts

- **NCT ID:** NCT01482247
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2016-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01482247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01482247, "L-Arginine, Vascular Response and Mechanisms". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01482247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*